Association of Hysteroscopic vs Laparoscopic Sterilization With Procedural, Gynecological, and Medical Outcomes
- 23 January 2018
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 319 (4), 375-387
- https://doi.org/10.1001/jama.2017.21269
Abstract
Question Are there clinically important risks associated with hysteroscopic sterilization compared with laparoscopic sterilization? Findings In this cohort study of 105 357 women who underwent a first sterilization, the use of hysteroscopic sterilization was significantly associated with lower immediate risk of procedural complications than laparoscopic sterilization (0.13% vs 0.78% for surgical complications and 0.06% vs 0.11% for medical complications); and higher risk of gynecological complications with 4.83% vs 0.69% for sterilization failure and 5.65% vs 1.76% for gynecological reoperation over 1 year; these differences persisted over 3 years, although attenuated. Risk of medical outcomes was not significantly increased over 1 year or over 3 years. Meaning These findings do not support an increased risk of medical outcomes related to hysteroscopic sterilization. Importance Safety of hysteroscopic sterilization has been recently questioned following reports of general symptoms such as allergy, tiredness, and depression in addition to associated gynecological results such as pelvic pain, perforation of fallopian tubes or uterus, and unwanted pregnancy. Objective To compare the risk of reported adverse events between hysteroscopic and laparoscopic sterilization. Design, Setting, and Participants French nationwide cohort study using the national hospital discharge database linked to the health insurance claims database. Women aged 30 to 54 years receiving a first hysteroscopic or laparoscopic sterilization between 2010 and 2014 were included and were followed up through December 2015. Exposures Hysteroscopic sterilization vs laparoscopic sterilization. Main Outcomes and Measures Risks of procedural complications (surgical and medical) and of gynecological (sterilization failure that includes salpingectomy, second sterilization procedure, or pregnancy; pregnancy; reoperation) and medical outcomes (all types of allergy; autoimmune diseases; thyroid disorder; use of analgesics, antimigraines, antidepressants, benzodiazepines; outpatient visits; sickness absence; suicide attempts; death) that occurred within 1 and 3 years after sterilization were compared using inverse probability of treatment–weighted Cox models. Results Of the 105 357 women included (95.5% of eligible participants; mean age, 41.3 years [SD, 3.7 years]), 71 303 (67.7% ) underwent hysteroscopic sterilization, and 34 054 (32.3%) underwent laparoscopic sterilization. During the hospitalization for sterilization, risk of surgical complications for hysteroscopic sterilization was lower: 0.13% for hysteroscopic sterilization vs 0.78% for laparoscopic sterilization (adjusted risk difference [RD], −0.64; 95% CI, −0.67 to −0.60) and was lower for medical complications: 0.06% vs 0.11% (adjusted RD, −0.05; 95% CI, −0.08 to −0.01). During the first year after sterilization, 4.83% of women who underwent hysteroscopic sterilization had a higher risk of sterilization failure than the 0.69% who underwent laparoscopic sterilization (adjusted hazard ratio [HR], 7.11; 95% CI, 5.92 to 8.54; adjusted RD, 4.23 per 100 person-years; 95% CI, 3.40 to 5.22). Additionally, 5.65% of women who underwent hysteroscopic sterilization required gynecological reoperation vs 1.76% of women who underwent laparoscopic sterilization (adjusted HR, 3.26; 95% CI, 2.90 to 3.67; adjusted RD, 4.63 per 100 person-years; 95% CI, 3.38 to 4.75); these differences persisted after 3 years, although attenuated. Hysteroscopic sterilization was associated with a lower risk of pregnancy within the first year of the procedure but was not significantly associated with a difference in risk of pregnancy by the third year (adjusted HR, 1.04; 95% CI, 0.83-1.30; adjusted RD, 0.01 per 100 person-years; 95% CI, −0.04 to 0.07). Risks of medical outcomes were not significantly increased with hysteroscopic sterilization compared with laparoscopic sterilization. Conclusions and Relevance Among women undergoing first sterilization, the use of hysteroscopic sterilization was significantly associated with higher risk of gynecological complications over 1 year and over 3 years than was laparoscopic sterilization. Risk of medical outcomes was not significantly increased over 1 year or over 3 years. These findings do not support increased medical risks associated with hysteroscopic sterilization.This publication has 36 references indexed in Scilit:
- Complications of hysteroscopic Essure® sterilisation: report on 4306 procedures performed in a single centreBJOG: An International Journal of Obstetrics and Gynaecology, 2012
- Role of Hysterectomy in the Treatment of Chronic Pelvic PainObstetrics & Gynecology, 2011
- Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitusPharmacoepidemiology and Drug Safety, 2010
- La pratique française de la pose des implants de stérilisation tubaire Essure®Gynécologie Obstétrique & Fertilité, 2009
- Ecological association between a deprivation index and mortality in France over the period 1997 – 2001: variations with spatial scale, degree of urbanicity, age, gender and cause of deathBMC Public Health, 2009
- Success rate and patient satisfaction with the Essure™ sterilisation in an outpatient setting: a prospective study of 857 womenBJOG: An International Journal of Obstetrics and Gynaecology, 2007
- Microinsert nonincisional hysteroscopic sterilizationObstetrics & Gynecology, 2003
- Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II studyHuman Reproduction, 2003
- Hysterectomy subsequent to laparoscopic sterilizationEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1990
- Hysterectomy following sterilizationBJOG: An International Journal of Obstetrics and Gynaecology, 1982